IP Library Granted Patent US 7,575,759
Granted Patent B2
US 7,575,759 · App. 10/330,578 · Granted Aug 18, 2009

Tissue engineering scaffolds

Assignee: The Regents of the University of Michigan
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,575,759
App. No.
10/330,578
Granted
Aug 18, 2009
Kind
B2
Abstract

The present invention relates to methods and compositions for the production of scaffolds, such scaffolds to be used for a variety of purposes, including tissue engineering. More specifically, the present invention relates to the use of fused crystals, such as fused salt crystals to form a framework. The methods for producing the scaffolds of this invention improve the porosity, interconnectivity and ease of manufacture as compared to prior art methods.

Claims (30)

1. A method, comprising;

a) providing

i) a plurality of particles, said particles comprising a porogen comprising salt crystals and

ii) a solution comprising a biocompatible polymer;

b) exposing said porogen to between approximately 90%-100% humidity for a duration ranging between 1 hour-36 hours such that said porogen fuses together to produce a framework comprising a frame and free space between said fused porogen, wherein said free space increases as said duration increases;

c) contacting said framework with said solution under conditions such that said solution fills greater than 75% of said free space;

d) treating said solution such that said polymer forms a scaffold; and

e) removing said fused porogen from said scaffold.

2. The method of claim 1 , wherein said salt crystals are selected from the group consisting of calcium chloride, sodium chloride, sodium phosphate, potassium chloride, potassium phosphate, calcium phosphate and magnesium chloride.

3. The method of claim 1 , wherein said polymer in said polymer solution is selected from the group consisting of a polyester, a poly(alpha-hydroxy ester), a polyether, a polystyrene and polymethylmethacrylate.

4. The method of claim 3 , wherein said polyester is poly(lactide-co-glycolide).

5. The method of claim 3 , wherein said polyether is polyethylene oxide or polyethylene glycol.

6. The method of claim 1 , wherein said treating of step (d) comprises evaporating said polymer solution.

7. The method of claim 1 , wherein said removing of step (e) comprises dissolving said fused salt crystals.

8. The method of claim 1 , wherein said scaffold after step (e) comprises cells.

9. The method of claim 1 , wherein said step b) additionally comprises exposing said porogen to positive pressure such that said free space between said fused porogen is controlled.

10. A method, consisting of;

a) providing

i) a plurality of particles, said particles comprising a porogen comprising salt crystals and

ii) a solution comprising a biocompatible polymer;

b) exposing said porogen to between approximately 90%-100% humidity for a duration ranging between 10 minutes-36 hours such that said porogen fuses together to produce a framework comprising a frame and free space between said fused porogen, wherein said free space increases as said duration increases;

c) contacting said framework with said solution under conditions such that said solution fills greater than 75% of said free space;

d) treating said solution such that said polymer forms a scaffold; and

e) removing said fused porogen from said scaffold.

11. The method of claim 10 , wherein said salt crystals are selected from the group consisting of calcium chloride, sodium chloride, sodium phosphate, potassium chloride, potassium phosphate, calcium phosphate and magnesium chloride.

12. The method of claim 10 , wherein said polymer in said polymer solution is selected from the group consisting of a polyester, a poly(alpha-hydroxy ester), a polyether, a polystyrene and polymethylmethacrylate.

13. The method of claim 12 , wherein said polyester is poly(lactide-co-glycolide).

14. The method of claim 12 , wherein said polyether is polyethylene oxide or polyethylene glycol.

15. The method of claim 10 , wherein said treating of step (d) comprises evaporating said polymer solution.

16. The method of claim 10 , wherein said removing of step (e) comprises dissolving said fused salt crystals.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 1, 2018
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047647/0433 →
CONFIRMATORY LICENSE Recorded Aug 29, 2016
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039851/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2003
From: MURPHY, WILLIAM L.; DENNIS, ROBERT G.; MOONEY, DAVID J.
To: REGENTS OF THE UNIVERSITY OF MICHIGAN,THE
Reel/Frame 014296/0678 →
Continuity (2)
Provisional Application 6034577500 · Jan 2, 2002
Related Publication 20040026811A1 · Feb 12, 2004